tiprankstipranks
Sensus Healthcare (SRTS)
NASDAQ:SRTS

Sensus Healthcare (SRTS) Technical Analysis

287 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Sensus Healthcare’s (SRTS) Moving Averages Convergence Divergence (MACD) indicator is 0.16, suggesting Sensus Healthcare is a Sell.
Sensus Healthcare’s (SRTS) 20-Day exponential moving average is 5.46, while Sensus Healthcare’s (SRTS) share price is $6.03, making it a Buy.
Sensus Healthcare’s (SRTS) 50-Day exponential moving average is 5.15, while Sensus Healthcare’s (SRTS) share price is $6.03, making it a Buy.

Sensus Healthcare (SRTS) Pivot Points

Jul 16, 2024, 04:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.20
5.46
5.81
6.07
6.42
6.68
7.03
Fibonacci
5.46
5.69
5.83
6.07
6.30
6.44
6.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sensus Healthcare (SRTS) Moving Averages

Jul 16, 2024, 04:58 AM
Period
Simple
Exponential
MA5
5.74Buy
5.82Buy
MA10
5.47Buy
5.61Buy
MA20
5.31Buy
5.46Buy
MA50
5.32Buy
5.15Buy
MA100
4.53Buy
4.65Buy
MA200
3.60Buy
3.94Buy
Sensus Healthcare’s (SRTS) 10-Day exponential moving average is 5.61, while Sensus Healthcare’s (SRTS) share price is $6.03, making it a Buy.
Sensus Healthcare’s (SRTS) 100-Day exponential moving average is 4.65, while Sensus Healthcare’s (SRTS) share price is $6.03, making it a Buy.
Sensus Healthcare’s (SRTS) stock price is $6.03 and Sensus Healthcare’s (SRTS) 50-day simple moving average is 5.32, creating a Buy signal.
Sensus Healthcare’s (SRTS) stock price is $6.03 and Sensus Healthcare’s (SRTS) 100-day simple moving average is 4.53, creating a Buy signal.
Sensus Healthcare’s (SRTS) stock price is $6.03 and Sensus Healthcare’s (SRTS) 200-day simple moving average is 3.60, creating a Buy signal.

Sensus Healthcare (SRTS) Technical Indicators

Jul 16, 2024, 04:58 AM
Name
Value
Implied Action
RSI (14)
62.03
Neutral
STOCH (9,6)
83.42
Sell
STOCHRSI (14)
84.65
Sell
MACD (12,26)
0.16
Sell
ADX (14)
20.80
Neutral
Williams %R
-17.47
Sell
CCI (14)
201.13
Sell
ATR (14)
0.40
-
Ultimate Oscillator
55.83
Neutral
ROC
21.57
Buy
Sensus Healthcare’s (SRTS) Relative Strength Index (RSI) is 62.03, creating a Neutral signal.
Sensus Healthcare’s (SRTS) Trend Strength Indicator (ADX) is 20.80, creating a Neutral signal.
Sensus Healthcare’s (SRTS) Commodity Channel Index (CCI) is 201.13, creating a Sell signal.
Sensus Healthcare’s (SRTS) Price Rate of Change (ROC) is 21.57, creating a Buy signal.

FAQ

Is SRTS a Buy, Hold, or Sell?
Based on SRTS’s technical indicators, SRTS is a Buy.
    What is SRTS’s RSI (14)?
    SRTS’s RSI (14) is 62.03, which suggests SRTS is a Neutral.
      What is SRTS’s MACD?
      SRTS’s MACD is 0.16, which suggests SRTS is a Sell.
        What is SRTS’s 5-day moving average?
        SRTS’s 5-day moving average is 5.74, which suggests SRTS is a Buy.
          What is SRTS’s 20-day moving average?
          SRTS 20-day moving average is 5.31, which suggests SRTS is a Buy.
            What is SRTS’s 50-day moving average?
            SRTS’s 50-day moving average is 5.32, which suggests SRTS is a Buy.
              What is SRTS’s 200-day moving average?
              SRTS’s 200-day moving average is 3.60, which suggests SRTS is a Buy.
                What is SRTS’s Williams % R (14)?
                SRTS’s Williams % R (14) is -17.47, which suggests SRTS is a Sell.
                  What is SRTS’s CCI (14)?
                  SRTS’s CCI (14) is 201.13, which suggests SRTS is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis